probiotic glp-1 Pendulum Therapeutics Introduces Pendulum GLP Low FODMAP Certified Advanced Probiotic
Description
Most of the lost weight tends to return
In addition, it has invested billions of dollars in expanding its manufacturing facilities
A large 2026 study of people who discontinued a GLP-1 medication found that just 14% adopted structured lifestyle changes
Murata, Y., et al
Our 2025 study in JMIR Formative Research examined 12-month outcomes for participants using semaglutide with behavioural support and found 1 : 19.1% average weight loss at 12 months for active subscribers 77.7% achieved at least 10% weight loss 61.5% achieved at least 15% weight loss 69% reported no side effects by month 12 These are completer results (people who stayed on the programme for 12 months), not intent-to-treat
